CollimateHealth develops a clinically scalable microbeam radiation technology designed to reshape the way cancer is treated. Its microbeam radiation therapy uses ultra-narrow beams to trigger intense tumor cell death, activate the immune system, and enhance chemo- and immunotherapy with fewer side effects.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| €6 M | Jun, 2026 | seed |
Industries
Frequently Asked Questions
Where is CollimateHealth located?
CollimateHealth is located in Munich, Germany.
What industries does CollimateHealth operate in?
CollimateHealth operates in the following industries: healthtech, medtech, oncology, radiation therapy.
Who are the investors in CollimateHealth?
The investors in CollimateHealth are: VP Venture Partners, Positron, Xista Science Ventures, HTGF | High-Tech Gründerfonds, Caesar.